TLR2 Stimulation Increases Cellular Metabolism in CD8+ T Cells and Thereby Enhances CD8+ T Cell Activation, Function, and Antiviral Activity

Key Points TLR2 directly regulates the anti-CD3–activated CD8+ T cells independently on APCs. Bioenergy metabolism is important for TLR2-mediated enhancement of CD8+ T cells. TLR2 enhances the antiviral CD8+ T cell response and the efficacy of HBV vaccine. TLR2 serves as a costimulatory molecule on activated T cells. However, it is unknown how the functionality and antiviral activity of CD8+ T cells are modulated by direct TLR2 signaling. In this study, we looked at the TLR2-mediated enhancement of TCR-driven CD8+ T cell activation in vitro and in woodchuck hepatitis virus transgenic mice. In vitro stimulation of CD8+ T cells purified from C57BL/6 mice showed that TLR2 agonist Pam3CSK4 directly enhanced the TCR-dependent CD8+ T cell activation. Transcriptome analysis revealed that TLR2 signaling increased expression of bioenergy metabolism-related genes in CD8+ T cells, such as IRF4, leading to improved glycolysis and glutaminolysis. This was associated with the upregulation of genes related to immune regulation and functions such as T-bet and IFN-γ. Glycolysis and glutaminolysis were in turn essential for the TLR2-mediated enhancement of T cell activation. Administration of TLR2 agonist Pam3CSK4 promoted the expansion and functionality of vaccine-primed, Ag-specific CD8+ T cells in both wild type and transgenic mice and improved viral suppression. Thus, TLR2 could promote CD8+ T cell immunity through regulating the energy metabolism.

[1]  B. Nicolet,et al.  Costimulation through TLR2 Drives Polyfunctional CD8+ T Cell Responses , 2018, The Journal of Immunology.

[2]  Jia Liu,et al.  Pre-Activation of Toll-Like Receptor 2 Enhances CD8+ T-Cell Responses and Accelerates Hepatitis B Virus Clearance in the Mouse Models , 2018, Front. Immunol..

[3]  Mengji Lu,et al.  Differentially Expressed Intrahepatic Genes Contribute to Control of Hepatitis B Virus Replication in the Inactive Carrier Phase , 2018, The Journal of infectious diseases.

[4]  D. Pei,et al.  Toll-like receptor 2 costimulation potentiates the antitumor efficacy of CAR T Cells , 2018, Leukemia.

[5]  Jia Liu,et al.  TLR2 Stimulation Strengthens Intrahepatic Myeloid-Derived Cell-Mediated T Cell Tolerance through Inducing Kupffer Cell Expansion and IL-10 Production , 2018, The Journal of Immunology.

[6]  Zhiyong Ma,et al.  Interaction between Hepatitis B Virus and Toll-Like Receptors: Current Status and Potential Therapeutic Use for Chronic Hepatitis B , 2018, Vaccines.

[7]  Jia Liu,et al.  TLR2 Expression in Peripheral CD4+ T Cells Promotes Th17 Response and Is Associated with Disease Aggravation of Hepatitis B Virus-Related Acute-On-Chronic Liver Failure , 2017, Front. Immunol..

[8]  J. Buer,et al.  The IL-1R/TLR signaling pathway is essential for efficient CD8+ T-cell responses against hepatitis B virus in the hydrodynamic injection mouse model , 2017, Cellular & Molecular Immunology.

[9]  M. Ferracin,et al.  Targeting mitochondrial dysfunction can restore antiviral activity of exhausted HBV-specific CD8 T cells in chronic hepatitis B , 2017, Nature Medicine.

[10]  D. Veale,et al.  Resolution of TLR2-induced inflammation through manipulation of metabolic pathways in Rheumatoid Arthritis , 2017, Scientific Reports.

[11]  V. Boussiotis.  Molecular and Biochemical Aspects of the PD-1 Checkpoint Pathway. , 2016, The New England journal of medicine.

[12]  E. Wherry,et al.  Bioenergetic Insufficiencies Due to Metabolic Alterations Regulated by the Inhibitory Receptor PD-1 Are an Early Driver of CD8(+) T Cell Exhaustion. , 2016, Immunity.

[13]  C. Frezza,et al.  Distinct Metabolic Requirements of Exhausted and Functional Virus-Specific CD8 T Cells in the Same Host , 2016, Cell reports.

[14]  M. Wolkers,et al.  TLR-Mediated Innate Production of IFN-γ by CD8+ T Cells Is Independent of Glycolysis , 2016, The Journal of Immunology.

[15]  T. Block,et al.  Chronic hepatitis B: A wave of new therapies on the horizon. , 2015, Antiviral research.

[16]  A. Kallies,et al.  Synchronizing transcriptional control of T cell metabolism and function , 2015, Nature Reviews Immunology.

[17]  B. Liao,et al.  Aberrant expression and dysfunction of TLR2 and its soluble form in chronic HBV infection and its regulation by antiviral therapy. , 2015, Antiviral research.

[18]  Zhiyong Ma,et al.  Contribution of Toll-like receptors to the control of hepatitis B virus infection by initiating antiviral innate responses and promoting specific adaptive immune responses , 2014, Cellular and Molecular Immunology.

[19]  A. Bertoletti,et al.  The immune tolerant phase of chronic HBV infection: new perspectives on an old concept , 2014, Cellular and Molecular Immunology.

[20]  Linda V. Sinclair,et al.  Metabolic regulation of hepatitis B immunopathology by myeloid-derived suppressor cells , 2015, Nature Medicine.

[21]  Baoju Wang,et al.  Woodchuck hepatitis virus core antigen-based DNA and protein vaccines induce qualitatively different immune responses that affect T cell recall responses and antiviral effects. , 2015, Virology.

[22]  Mengji Lu,et al.  Toll-like receptor (TLR)-mediated innate immune responses in the control of hepatitis B virus (HBV) infection , 2014, Medical Microbiology and Immunology.

[23]  R. Thimme,et al.  Restoration of HBV-specific CD8+ T cell function by PD-1 blockade in inactive carrier patients is linked to T cell differentiation. , 2014, Journal of hepatology.

[24]  A. Regev,et al.  The transcription factor BATF operates as an essential differentiation checkpoint in early effector CD8+ T cells , 2014, Nature Immunology.

[25]  D. Scott‐Algara,et al.  Anti-HBV DNA vaccination does not prevent relapse after discontinuation of analogues in the treatment of chronic hepatitis B: a randomised trial—ANRS HB02 VAC-ADN , 2014, Gut.

[26]  Jia Liu,et al.  Enhancing Virus-Specific Immunity In Vivo by Combining Therapeutic Vaccination and PD-L1 Blockade in Chronic Hepadnaviral Infection , 2014, PLoS pathogens.

[27]  O. Dirsch,et al.  Novel Woodchuck Hepatitis Virus (WHV) Transgene Mouse Models Show Sex-Dependent WHV Replicative Activity and Development of Spontaneous Immune Responses to WHV Proteins , 2013, Journal of Virology.

[28]  M. Kaplan,et al.  Interferon regulatory factor 4 sustains CD8(+) T cell expansion and effector differentiation. , 2013, Immunity.

[29]  Jia Liu,et al.  TLR1/2 Ligand–Stimulated Mouse Liver Endothelial Cells Secrete IL-12 and Trigger CD8+ T Cell Immunity In Vitro , 2013, The Journal of Immunology.

[30]  W. Shi,et al.  The transcription factor IRF4 is essential for TCR affinity–mediated metabolic programming and clonal expansion of T cells , 2013, Nature Immunology.

[31]  Y. Wen,et al.  Results of a phase III clinical trial with an HBsAg-HBIG immunogenic complex therapeutic vaccine for chronic hepatitis B patients: experiences and findings. , 2013, Journal of hepatology.

[32]  Jia Liu,et al.  Combination of DNA Prime – Adenovirus Boost Immunization with Entecavir Elicits Sustained Control of Chronic Hepatitis B in the Woodchuck Model , 2013, PLoS pathogens.

[33]  Zhenghong Yuan,et al.  Hepatitis B Virus Surface Antigen Selectively Inhibits TLR2 Ligand–Induced IL-12 Production in Monocytes/Macrophages by Interfering with JNK Activation , 2013, The Journal of Immunology.

[34]  J. Rathmell,et al.  Metabolic regulation of T lymphocytes. , 2013, Annual review of immunology.

[35]  W. Rosenberg,et al.  The Third Signal Cytokine IL-12 Rescues the Anti-Viral Function of Exhausted HBV-Specific CD8 T Cells , 2013, PLoS pathogens.

[36]  D. Green,et al.  Metabolic checkpoints in activated T cells , 2012, Nature Immunology.

[37]  Jia Liu,et al.  Role of Toll-like receptor 2 in the immune response against hepadnaviral infection. , 2012, Journal of hepatology.

[38]  Mengji Lu,et al.  DNA Prime-Adenovirus Boost Immunization Induces a Vigorous and Multifunctional T-Cell Response against Hepadnaviral Proteins in the Mouse and Woodchuck Model , 2012, Journal of Virology.

[39]  A. Bertoletti,et al.  Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection , 2011, Gut.

[40]  T. Sparwasser,et al.  Transient depletion of regulatory T cells in transgenic mice reactivates virus-specific CD8+ T cells and reduces chronic retroviral set points , 2011, Proceedings of the National Academy of Sciences.

[41]  S. Markovic,et al.  Cancer esearch oenvironment and Immunology plifying TLR-MyD 88 Signals within Tumor-Specific ells Enhances Antitumor Activity to Suboptimal R els of Weakly Immunogenic Tumor , 2010 .

[42]  E. Davila,et al.  When Toll-like receptor and T-cell receptor signals collide: a mechanism for enhanced CD8 T-cell effector function. , 2010, Blood.

[43]  G. Gerken,et al.  Toll‐like receptor‐induced innate immune responses in non‐parenchymal liver cells are cell type‐specific , 2010, Immunology.

[44]  F. Chisari,et al.  Immune effectors required for hepatitis B virus clearance , 2009, Proceedings of the National Academy of Sciences.

[45]  L. Turka,et al.  The contribution of direct TLR signaling to T cell responses , 2009, Immunologic research.

[46]  J. Marvel,et al.  TLR2 Engagement on CD8 T Cells Enables Generation of Functional Memory Cells in Response to a Suboptimal TCR Signal1 , 2009, The Journal of Immunology.

[47]  Zhan-qing Zhang,et al.  Expression profiles and function of Toll-like receptors 2 and 4 in peripheral blood mononuclear cells of chronic hepatitis B patients. , 2008, Clinical immunology.

[48]  Lieping Chen,et al.  Interaction between B7-H1 and PD-1 determines initiation and reversal of T-cell anergy. , 2007, Blood.

[49]  G. Gerken,et al.  Interferon-alpha response in chronic hepatitis B-transfected HepG2.2.15 cells is partially restored by lamivudine treatment. , 2007, World journal of gastroenterology.

[50]  S. Riordan,et al.  Reduced Expression of Toll-Like Receptor 2 on Peripheral Monocytes in Patients with Chronic Hepatitis B , 2006, Clinical and Vaccine Immunology.

[51]  S. Akira,et al.  TLR2 engagement on CD8 T cells lowers the thresholdfor optimal antigen‐induced T cell activation , 2006, European journal of immunology.

[52]  L. Jones,et al.  TLR2 is expressed on activated T cells as a costimulatory receptor. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[53]  W. Lindenmaier,et al.  Enhanced Effector and Memory CTL Responses Generated by Incorporation of Receptor Activator of NF-κB (RANK)/RANK Ligand Costimulatory Molecules into Dendritic Cell Immunogens Expressing a Human Tumor-Specific Antigen 12 , 2003, The Journal of Immunology.

[54]  R. Purcell,et al.  CD8+ T Cells Mediate Viral Clearance and Disease Pathogenesis during Acute Hepatitis B Virus Infection , 2003, Journal of Virology.

[55]  D. Green,et al.  Nonlymphoid Fas ligand in peptide-induced peripheral lymphocyte deletion , 2002, Proceedings of the National Academy of Sciences of the United States of America.